Xeris Biopharma Holdings XERS SEC Filings

NASDAQ XERS
$8.39 -0.09 (-1.12%)
As of: Sep 9, 2026 · 12:06 PM EDT
EDGAR Disclosures

Regulatory Filings

Source SEC EDGAR

Every regulatory document Xeris Biopharma Holdings, Inc. (XERS) has filed with the SEC, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

# Form Type Form Group Accession Date Filing Index